PharmaLectures.com

Courses › Regulatory affairs by region › European Union: Clinical trials under CTIS and Regulation 536/2014 for CRO and sponsor staff

European Union: Clinical trials under CTIS and Regulation 536/2014 for CRO and sponsor staff

Your team files clinical trial applications that clear first review.

CTIS, the Clinical Trials Information System, is the single EU portal and database for clinical trial applications under Regulation (EU) No 536/2014. It went live on 31 January 2022 and is run by the European Medicines Agency. Sponsors submit one application for all the member states concerned: Part I is assessed jointly under a reporting member state, Part II nationally by each country. Since 31 January 2025 every ongoing trial in the EU must be run under the Regulation in CTIS. This course trains CRO and sponsor staff to use it.

  • 10 audio modulesthree lengths each
  • 1 h 40 min to 8 h 20 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why CTIS training matters

A sponsor calls because the reporting Member State sent a request for information on your team's Clinical Trials Information System (CTIS) application. The reply clock runs, the protocol and form disagree, and recruitment waits. The sponsor asks if another contract research organisation would do better.

What changes after this course

Your team files Part I and Part II complete, answers requests for information inside the window, and handles modifications and safety reports as Regulation (EU) No 536/2014 requires. You hold a certificate for every learner and a training record for each person, ready for auditors.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

CTIS training: what this course gives your people

A sponsor sends you a protocol and asks which documents go into Part I and which into Part II. You answer from Annex I of Regulation (EU) No 536/2014, not from memory. Your applicant builds the dossier with the form, cover letter and protocol saying the same thing, and the reporting Member State has less to query at validation.

The request for information arrives on a Friday. Your regulatory lead already knows that the Regulation sets the pace, who drafts the scientific answer, and who checks the revised documents. The reply goes in complete, the response date is tracked, and the application does not lapse while someone is away.

Project managers stop being the bottleneck for access. When a new colleague joins or an applicant leaves, they know which role to request, who in the sponsor workspace approves it, and how sponsor responsibilities move across. Sites and contract research organisation staff reach CTIS before the submission date, not after it.

Quality assurance reads the safety chapter with a checklist in hand. Chapter VII sets when a suspected unexpected serious adverse reaction goes to EudraVigilance and what the annual report holds. Your auditors see a team that can cite Articles 37, 42 and 43, with modifications and end-of-trial notices recorded on time.

Who needs CTIS training

  • Regulatory Affairs Manager

    Before every filing, they check whether the protocol, the application form and the Part I documents agree. This gives them the Annex I checklist and the validation habits that stop the first request for information.

  • Clinical Quality Assurance Specialist

    In an internal audit, they find a late safety report and must cite the Article that sets the clock. They leave with the references and the record to show the auditor.

  • Business Development Lead

    A sponsor asks in the pitch meeting what changes under the Regulation and how long approval takes. They answer from the Regulation itself, not from a slide someone wrote last year.

  • Clinical Project Manager

    A site contact cannot upload a document because the access request never went through. They know which role to request, who approves it, and how to keep the submission date.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Name the main differences between Directive 2001/20/EC and Regulation (EU) No 536/2014 when a sponsor asks.
  2. Request the right CTIS role for each team member and say who in the sponsor workspace approves it.
  3. Sort application documents into Part I and Part II using Annex I, and prepare the initial submission in CTIS.
  4. Draft a reply to a request for information and record the response date that keeps the application from lapsing.
  5. Decide whether a mid-study change is a substantial modification and file it without stopping the trial.
  6. Report a suspected unexpected serious adverse reaction to EudraVigilance within the clock that Article 42 sets.
  7. Submit the end-of-trial notification and set the date for the separate summary of results.

What the company gets

  • Your applications reach assessors with fewer validation questions, so recruitment starts closer to the date you promised the sponsor.
  • Every learner holds a certificate and a training record, so you answer an inspector's question about staff training with a document.
  • Reply dates for requests for information sit in one tracked place, so no application lapses because someone was on leave.
  • Your business development team quotes the Regulation correctly in tenders and sponsor questionnaires, and the answer matches what your regulatory staff do.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 10 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 40 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard4 h 10 min25 min a module, for regulatory, quality and business-development staff
Expanded8 h 20 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing1 h 40 min
Regulatory affairsStandard4 h 10 min
Quality assurance and Qualified PersonStandard4 h 10 min

CTIS course outline: 10 modules

10 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map the European Union clinical trials landscape and who decides what

    • Why a filing habit from Directive 2001/20/EC now costs you a validation round, and what replaces it.
    • How to tell a sponsor in a minute what the European Medicines Agency runs and what Member States decide.
    • What to do when a local question belongs with a Member State contact point instead of the portal.
  2. 2Apply the core principles of Regulation (EU) No 536/2014 to live trials

    • The coordinated assessment route that lets you quote a sponsor one submission path instead of several.
    • Why the transparency rules in Article 81 decide what you can mark as confidential before you upload.
    • How to map each duty in the Regulation to a step in your standard operating procedures.
  3. 3Assign CTIS user roles so no applicant waits for access

    • Which CTIS sponsor role fits an administrator, a submitter and a reviewer, so each sees only what they need.
    • How to set up access for a new colleague early, so the submission date never waits on a login.
    • What to do when an applicant leaves and the sponsor responsibilities in CTIS must pass to someone else.
  4. 4Structure Part I of the application so assessors find answers fast

    • The Annex I documents that belong in Part I, so the validation check finds nothing missing.
    • How to keep the application form fields and the protocol saying the same thing, so assessors stop querying.
    • When a Part I document must be updated after submission and when you should simply leave it alone.
  5. 5Assemble Part II so each Member State accepts it the first time

    • The national documents each Member State expects in Part II, listed before you start the dossier.
    • How to prepare the informed consent form and recruitment material so ethics reviewers have less to question.
    • What to hold ready on site suitability, so a Member State question gets a short, documented answer.
  6. 6Submit the initial application in CTIS without validation errors

    • The click path from a new trial in CTIS to a submitted application, in the order the system expects.
    • Why a file in the wrong format or structure stops at validation, and how to prepare files that pass.
    • How to run a last check that catches the usual slips between the form, the cover letter and the protocol.
  7. 7Answer requests for information before the clock runs out

    • Which requests for information need a scientific answer and which only need a corrected document.
    • How to write a reply that answers the assessor's concern once, so a second round never opens.
    • Why a missed response date lapses the application, and the tracker that keeps your team ahead.
  8. 8File substantial modifications in CTIS while the trial keeps running

    • When a change counts as a substantial modification under Chapter III and when it does not.
    • How to file a modification so the trial continues under the approved version while the review runs.
    • What to do when several modifications are open and Member States answer at different times.
  9. 9Report safety under Regulation (EU) No 536/2014 on the right clock

    • The clock that starts when the sponsor first hears of a suspected unexpected serious adverse reaction.
    • How reports reach EudraVigilance, so a missing case shows on your list before an inspector sees it.
    • What the annual safety report needs so the Member States have no reason to query it.
  10. 10Close out the trial and keep CTIS records inspection-ready

    • The end-of-trial notice that closes the trial in CTIS on time, with the dates you must record.
    • How to archive the trial master file for the 25 years Article 58 requires, with proof of where it sits.
    • When the summary of results is due and what it must contain, so no compliance finding follows.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about CTIS training

What is the difference between Part I and Part II in CTIS?

Part I covers the scientific and medicinal product side of the trial, such as the protocol, the investigator's brochure and the investigational medicinal product dossier. The member states concerned assess it together, led by a reporting member state. Part II covers national matters, such as informed consent, recruitment, site suitability and insurance, and each member state assesses it for its own territory.

How long does a sponsor have to answer a request for information in CTIS?

Under Regulation (EU) No 536/2014 the sponsor normally gets no more than 12 days to answer a request for information during the assessment of an initial application. If the answer is not submitted in time, the application is deemed to have lapsed in the member states concerned. That is why this course trains teams to assign CTIS roles and prepare answers before the clock starts.

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

10 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 40 min in the briefing length and 8 h 20 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 90 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team